Pandey Vishal, Dummula Krishna, Fraga Garth, Parimi Prabhu
Department of Pediatrics, Division of Neonatology, University of Kansas, School of Medicine, Kansas City, KS, USA.
J Pediatr Hematol Oncol. 2012 Oct;34(7):534-5. doi: 10.1097/MPH.0b013e3182678f1e.
Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.
重组促红细胞生成素正被用于早产儿治疗早产儿贫血。在这一人群中它被认为非常安全,尽管风险仍在评估中。我们报告了首例皮肤红细胞生成现象,这是重组促红细胞生成素的一种副作用,发生在一名极早早产儿身上,该患儿出现迟发性蓝莓松饼样皮疹。